Correlations of ultrasonic features with severity of liver cancer and p16 expression in patients with liver cancer

Abstract

This paper analyzes the correlations of ultrasonic features with clinical-pathological manifestations and p16 expression in patients with liver cancer. A total of 84 patients with primary liver cancer were randomly enrolled. The characteristics of liver cancer were examined via conventional ultrasound and contrast-enhanced ultrasound (CEUS) before operation. The p16 protein expressions in liver cancer and para-carcinoma tissues were detected via immunohistochemistry (IHC), and the correlations of p16 positive expression with ultrasound parameters were also analyzed. It was manifested via ultrasound that 6.4% (3/47) of stage I-II liver cancer showed the equal-echo change in portal phase, while others faded and showed the equal-echo change with 32.4% (12/37) of stage III-IV liver cancer. There were no statistically significant differences in ultrasonic features of patients in stage I-II and stage III-IV in the arterial and delayed phases (p>0.05). The positive expression rate of p16 protein in para-carcinoma tissues was 85.71% (72/84) which was significantly higher than that in liver cancer tissues (30.95%, 26/84) (p<0.05). Maximum intensity (IMAX), time to peak (TTP) and mean transit time (mTT) had no statistically significant differences between the p16 positive and negative groups, but there were statistically significant differences in rising slope (RS) and washout time (WT) (p<0.05). Correlation analyses revealed that the positive expression of p16 had no significant correlations with IMAX, mTT and TTP (p>0.05), but it positively correlated with RS (correlation coefficient r=0.377, p<0.05) and negatively correlated with WT (r=-0.410, p<0.05).Conventional ultrasound and CEUS can evaluate the expression of p16 protein in liver cancer repeatedly and non-invasively. The evaluations therefore have great significance in clinical treatment of liver cancer.

Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer

“…Color ultrasound enables the screening of liver cancer lesions, determining the presence or absence of a tumor, and analysis of the nature and composition of a tumor. In addition, CDFI enables the monitoring of blood flow inside a lesion and its surroundings, obtaining the related information, etc., allowing for a qualitative diagnosis of the lesion based on the hemodynamic characteristics [15]. Contrast-enhanced ultrasonography (CEUS) enables the early detection of vascular lesions within a tumor.…”

Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies

“…But while it has been reported sensitive in detection of even asymptomatic tumors, factors like doubling time of the lesion and experience of the clinician in interpretation of the scan are critical for success. Different meta-analytic studies suggest that a combination of USG findings with clinico-pathological manifestations and other biomarkers, like p16 expression and serum alpha-fetoprotein (AFP), can have greater sensitivity for early-stage HCC than USG alone [21,22]. In a retrospective analysis involving [ 250 patients, Schwarze et al showed that contrast-enhanced USG demonstrated remarkable accuracy compared to MRI as a diagnostic gold standard [23].…”

Clinical Value Study on Contrast‐Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma

“…Among them, ultrasound and CT are used usually, but conventional ultrasound has some limitations, such as conventional CT with a longer scanning time. In addition, the advantage of contrast-enhanced ultrasound examination is that it can effectively improve the diagnosis sensitivity and specificity of PHC by real-time observation of blood perfusion in hepatic tissues, while enhanced CT is a focused examination after injection of radiography agent into suspect area on the basis of plain scan [7][8][9]. However, the international guidelines recommend enhanced CTas the first-line method of imaging examination for PHC at present, while contrast-enhanced ultrasound is only used as a second-line inspection means, with a controversy in diagnostic value.…”